Newswires
Submission of Matters to a Vote of Security Holders – Form 8-K
goco-20230523
UNITED STATES
WASHINGTON, DC 20549
GoHealth, Inc.
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 23, 2023
_________________________
(Exact name of registrant as specified in its charter)
_________________________
| 001-39390 | 85-0563805 | |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| 60654 | |
| (Address of principal executive offices) | ( |
(312) 386-8200
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
_________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425). |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12). |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)). |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | on which registered |
| Class A Common Stock, |
GOCO | The Nasdaq Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 23, 2023 , the Company held its 2023 Annual Meeting of Stockholders (the "Annual Meeting"). A total of 19,307,696 shares of the Company's Preferred Stock and Class A and Class B common stock (collectively, "Stock") were present in person or represented by proxy at the Annual Meeting, representing approximately 74% percent of the Company's outstanding Stock as of the March 28, 2023 record date. The following are the voting results for the proposals considered and voted upon at the Annual Meeting, each of which was described in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on April 11, 2023 .
Item 1 - Election of three Class III directors for a term of office expiring on the date of the annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified.
| Votes FOR | Votes WITHHELD | Broker Non-Votes | |
| 16,476,370 | 206,338 | 2,624,988 | |
| 16,482,346 | 200,362 | 2,624,988 | |
| 16,668,150 | 14,558 | 2,624,988 |
Item 2 - Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023 .
| Votes FOR | Votes AGAINST | Votes ABSTAINED | Broker Non-Votes |
| 19,286,046 | 12,192 | 9,458 | 0 |
Item 3 - Approval on an advisory basis, the compensation of the Company's named executive officers.
| Votes FOR | Votes AGAINST | Votes ABSTAINED | Broker Non-Votes |
| 16,604,620 | 73,103 | 4,985 | 2,624,988 |
Based on the foregoing voting results, Clinton P. Jones , Jeremy W. Gelber , and Karolina H. Hilu were elected as Class III directors and Items 2 and 3 were approved.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: | By: | /s/ |
|
|
Chief Legal Officer
|
Attachments
Disclaimer
SINGULAR GENOMICS SYSTEMS, INC. FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders
President Akufo-Addo Urges African Leaders to Support AfCFTA Boldly
Advisor News
- Succession planning: Building the future of your practice
- From loss to security: Supporting widowed clients with life insurance
- Plan now for lower Social Security benefits later
- The conversation almost no advisor is having yet
- Why advisors should offer retirement-longevity planning
More Advisor NewsAnnuity News
- Empower Annuity Insurance Company of America Trademark Application for “EMPOWER WHAT’S NEXT” Filed: Empower Annuity Insurance Company of America
- Industry pushes back on linking ‘financial strength’ to annuity illustrations
- Sammons Enterprises & Sammons Financial Group Respond to Reports
- The Manhattan Life Insurance Company Acquires Union Security Life Insurance Company of New York
- Cayman Islands premier to meet with U.S. reinsurance regulators
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- New Influenza Study Results from University of Auckland Described (Risk Management In Deadly Times: the Us Life Insurance Industry In the 1918-9 Influenza Pandemic): Influenza
- AM Best Assigns Credit Ratings to InEvo Re Ltd.
- Life Insurance Awareness Month: Time to Reassess Your Coverage
- U-Haul Holding Company Announces Twentieth Annual Virtual Analyst and Investor Meeting
- Securian Financial Increases Individual Life Retention to $10 Million, Strengthening Support for High-Net-Worth Life Insurance Market
More Life Insurance News